Consistent with the mechanism of action of MDM2-p53 antagonists, p53 wt neuroblastoma cell lines were significantly more sensitive to RG7388 compared to p53 mutant cell lines (P < 0.0001, Mann-Whitney test). The gene discussed is TP53; the disease is neuroblastoma.